M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 1.8 USD -5.76% Market Closed
Market Cap: 85.1m USD
Have any thoughts about
MDxHealth SA?
Write Note

MDxHealth SA
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MDxHealth SA
Research & Development Peer Comparison

Comparables:
GLPG
OXUR
CYAD

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
M
MDxHealth SA
NASDAQ:MDXH
Research & Development
-$11.4m
CAGR 3-Years
-30%
CAGR 5-Years
-21%
CAGR 10-Years
-7%
Galapagos NV
AEX:GLPG
Research & Development
-€429.4m
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Oxurion NV
XBRU:OXUR
Research & Development
-€9.8m
CAGR 3-Years
23%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Celyad Oncology SA
XBRU:CYAD
Research & Development
-€3.5m
CAGR 3-Years
44%
CAGR 5-Years
32%
CAGR 10-Years
N/A

See Also

What is MDxHealth SA's Research & Development?
Research & Development
-11.4m USD

Based on the financial report for Jun 30, 2024, MDxHealth SA's Research & Development amounts to -11.4m USD.

What is MDxHealth SA's Research & Development growth rate?
Research & Development CAGR 10Y
-7%

Over the last year, the Research & Development growth was -7%. The average annual Research & Development growth rates for MDxHealth SA have been -30% over the past three years , -21% over the past five years , and -7% over the past ten years .

Back to Top